Dia's artificial intelligence automation or point-of-care cardiac ultrasound on display at the 2021 Radiological Society of North America (RSNA) annual meeting. 
December 02, 2021
Mount Sinai Study Validates DiA Cardiac Ultrasound AI Algorithm and Finds it Comparable to Cardiac MRI
December 2, 2021 — Artificial intelligence (AI) vendor DiA Imaging Analysis was featured in a recent study presented by…
Read More
COVID-19 Linked to Heart Inflammation in College Athletes late-breaking study at RSNA 2021.
December 01, 2021
COVID-19 Linked to Heart Inflammation in College Athletes
December 1, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a…
Read More
Here is a list of all the AHA 2021 late-breaking clinical trials and studies. #AHA #AHA21 #AHA2021
By Dave Fornell, DAIC Editor
November 23, 2021
Late-breaking Science Presentations at the AHA 2021 Meeting
The following are the late-breaking science presentation sessions at the 2021 American Heart Association (AHA) 2021…
Read More
November 23, 2021
Novel Surgical Device Can Potentially Improve Outcomes of Coronary Bypass Grafting That Uses Leg Veins
November 23, 2021 —  A novel device called venous external support (VEST) may lead to increased longevity and…
Read More
Examples of COVID-19 caused clotting with multiple pulmonary embolisms (PE) in left image, and a large thrombus in the aortic arch. Images courtesy of RSNA and Margarita Revzin et al. Find more clinical images of COVID.
November 23, 2021
Antiplatelet Drug Class Does Not Increase Survival in Hospitalized Moderate COVID-19 Cases
November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents…
Read More
AI for Atrial Fibrillation. BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the company entered into a feasibility study with The Technion Research & Development Foundation Ltd.
November 22, 2021
BioSig Initiates AI Development With Technion to Uncover the Full Range of ECG and Intra-Cardiac Electrical Signals
November 22, 2021 — BioSig Technologies Inc., a medical technology company commercializing an innovative biomedical…
Read More
November 22, 2021
Atlantic Health System’s Morristown Medical Center Randomizes First Patient in World to New Study to Evaluate Treatment with TAVR for Moderate Aortic Stenosis
November 22, 2021 — Atlantic Health System’s Morristown Medical Center announced that it has enrolled the first patient…
Read More
Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results of a clinical study that proved Cardiologs’ deep learning AI outperforms the Apple Watch ECG algorithm in the detection of atrial arrhythmias (AA), which are related to stroke risks. The data was accepted for a moderated digital poster presentation at the American Heart Association (AHA) Scientific Sessions 2021. #AHA ECG Monitoring AI
November 22, 2021
New Study Shows Cardiologs' Deep Learning AI Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Arrhythmias
November 22, 2021 — Cardiologs, a leader in artificial intelligence (AI) cardiology diagnostics, announced the results…
Read More
November 22, 2021
Early Thrombosis After Iliac Stenting for Venous Outflow Occlusion Is Related to Disease Severity and Type of Anticoagulation
November 22, 2021 — Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral…
Read More
November 22, 2021
Improved Outcomes and Decreased Mortality in Aortic Dissections Achieved Using Care Plans Designed by Multidisciplinary Expertise
November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing…
Read More
EMPULSE Trial showed hospitalized adults taking empagliflozin had reduced rates of death or re-hospitalization due to acute heart failure. #AHA Heart Failure
November 19, 2021
Adults With Acute Heart Failure Benefit When Treated With a Type 2 Diabetes Medication
November 19, 2021 — Adults treated with empagliflozin during hospitalization for acute heart failure experienced a…
Read More
#AHA Stem Cell Therapy for Heart Failure Trial, DREAM-HF Trial. #AHA21
November 19, 2021
Stem Cell Therapy for Heart Failure Reduced Major Cardiac Events and Death
November 19, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with…
Read More
Rafael Díaz,M.D., director of Estudios Clínicos Latinoamérica in Rosario, Argentina
November 19, 2021
Prescription Omega-3 Pill Did Not Affect Outcome for Non-hospitalized Adults With COVID-19
November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated;…
Read More
Oral PCSK9 Inhibitor Lowering Cholesterol in First Human Trial
November 19, 2021
Oral PCSK9 Inhibitor Safe and Effective in Lowering Cholesterol in First Human Trial
November 19, 2021 — Results from two early clinical studies show the first version of an oral PCSK9-inhibitor…
Read More
Coronary Artery Bypass Grafting (CABG). #AHA21
November 18, 2021
Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A in Patients Undergoing CABG
November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating…
Read More
Repair of Tricuspid Valve Leak CTCR-MVS - Evaluating the Benefit of Concomitant Tricuspid Repair During Mitral Valve Surgery.
November 18, 2021
Repair of Tricuspid Valve Leak During Mitral Valve Surgery May Benefit Some Adults
November 18, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may…
Read More
Cardiovascular Surgery Ticagrelor - significant increase in bleeding when people had bypass surgery after two to three days of discontinuing ticagrelor. #AHA #AHA21
November 18, 2021
Time From Stopping Blood Thinner To Bypass Surgery May Be Shortened for Select Patients
November 18, 2021 — People who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery…
Read More
About 57% of the people with high blood pressure achieved normal blood pressure levels after 18 months of the village doctor-led intervention program.Blood Pressure Hypertension. #AHA21
November 18, 2021
Village Doctor-led Intervention Effective in BP Control, Adds Health Care Access Options
November 18, 2021 — Village doctors who were community health workers in rural China were trained and successfully…
Read More
November 18, 2021
Novel Algorithm on Wearable Devices Can Detect Irregular Heartbeat, May Prompt Early Care
November 18, 2021 — A novel software algorithm compatible with a wide range of smartwatches and fitness trackers…
Read More
The FDA said the Medtronic Micra leadless pacemaker may have a higher rate of serious complications due to cardiac perforations during implant and is trying to get more information on these incidents. 
November 18, 2021
FDA Warns Micra Leadless Pacing System May Have Risk of Major Complications Due to Cardiac Perforations
November 18, 2021 — The U.S. Food and Drug Administration (FDA) is reminding providers about the risk of major…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now